Literature DB >> 29417373

Practical issues for the management of hyponatremia in oncology.

Rossana Berardi1, Andrea Antonuzzo2, Livio Blasi3, Roberta Buosi4, Vito Lorusso5, Maria Rita Migliorino6, Vincenzo Montesarchio7, Nicoletta Zilembo8, Roberto Sabbatini9, Alessandro Peri10.   

Abstract

Hyponatremia is common in cancer patients and has a negative impact on outcomes and survival. Both the diagnosis and treatment of hyponatremia are challenging. Easy-to-use, practical guidelines are needed. The aim of this article is to discuss practical issues related to the diagnostic workup and management of hyponatremia, with particular attention to complex patients, such as those affected by neoplastic diseases. Admittedly, these patients may present several comorbidities, which may cause sodium alterations. In addition, multidrug therapy may precipitate serum sodium fall. An algorithm for the diagnosis and treatment of hyponatremia was also developed, based on the discussion of the results of a questionnaire completed by the authors and of the published recommendations/guidelines on hyponatremia. The goal was to produce an algorithm that was as simple as possible but still comprehensive, without compromising information completeness. Many explanatory notes were added with the aim of guiding clinicians throughout the management of complex patients with hyponatremia, such as those with cancer. The resulting algorithm and supporting literature are presented.

Entities:  

Keywords:  Antidiuretic hormone; Arginine vasopressin; Hyponatremia; SIADH; Tolvaptan; Water excretion

Mesh:

Substances:

Year:  2018        PMID: 29417373     DOI: 10.1007/s12020-018-1547-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  31 in total

Review 1.  Clinical practice. The syndrome of inappropriate antidiuresis.

Authors:  David H Ellison; Tomas Berl
Journal:  N Engl J Med       Date:  2007-05-17       Impact factor: 91.245

Review 2.  Disorders of plasma sodium--causes, consequences, and correction.

Authors:  Richard H Sterns
Journal:  N Engl J Med       Date:  2015-01-01       Impact factor: 91.245

3.  Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations.

Authors:  Joseph G Verbalis; Steven R Goldsmith; Arthur Greenberg; Cynthia Korzelius; Robert W Schrier; Richard H Sterns; Christopher J Thompson
Journal:  Am J Med       Date:  2013-10       Impact factor: 4.965

4.  Tolvaptan in hospitalized cancer patients with hyponatremia: a double-blind, randomized, placebo-controlled clinical trial on efficacy and safety.

Authors:  Abdulla K Salahudeen; Najeeba Ali; Marina George; Amit Lahoti; Shana Palla
Journal:  Cancer       Date:  2013-11-05       Impact factor: 6.860

5.  The Incidence of Hyponatraemia and Its Effect on the ECOG Performance Status among Lung Cancer Patients.

Authors:  Amitabha Sengupta; Sourindra Nath Banerjee; Nirendra Mohan Biswas; Debraj Jash; Kaushik Saha; Arnab Maji; Ankan Bandyopadhyaya; Sandip Agarwal
Journal:  J Clin Diagn Res       Date:  2013-08-01

Review 6.  Tumor-related hyponatremia.

Authors:  Adedayo A Onitilo; Ebenezer Kio; Suhail A R Doi
Journal:  Clin Med Res       Date:  2007-12-17

7.  Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis.

Authors:  Giovanni Corona; Corinna Giuliani; Joseph G Verbalis; Gianni Forti; Mario Maggi; Alessandro Peri
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

8.  Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.

Authors:  Richard J Gralla; Fatima Ahmad; Jaime D Blais; Joseph Chiodo; Wen Zhou; Linda A Glaser; Frank S Czerwiec
Journal:  Cancer Med       Date:  2017-03-02       Impact factor: 4.452

9.  A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.

Authors:  Claudia Petereit; Okan Zaba; Ishak Teber; Heike Lüders; Christian Grohé
Journal:  BMC Pulm Med       Date:  2013-08-29       Impact factor: 3.317

Review 10.  Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives.

Authors:  Bijin Thajudeen; Abdulla K Salahudeen
Journal:  Cancer Manag Res       Date:  2016-08-22       Impact factor: 3.989

View more
  5 in total

1.  Effects of low extracellular sodium on proliferation and invasive activity of cancer cells in vitro.

Authors:  Giada Marroncini; Benedetta Fibbi; Alice Errico; Cecilia Grappone; Mario Maggi; Alessandro Peri
Journal:  Endocrine       Date:  2019-11-29       Impact factor: 3.633

2.  Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study.

Authors:  Tomoko Kobayashi; Shintaro Iwama; Yoshinori Yasuda; Norio Okada; Takayuki Okuji; Masaaki Ito; Takeshi Onoue; Motomitsu Goto; Mariko Sugiyama; Taku Tsunekawa; Hiroshi Takagi; Daisuke Hagiwara; Yoshihiro Ito; Hidetaka Suga; Ryoichi Banno; Kenji Yokota; Tetsunari Hase; Masahiro Morise; Naozumi Hashimoto; Masahiko Ando; Yasushi Fujimoto; Hideharu Hibi; Michihiko Sone; Yuichi Ando; Masashi Akiyama; Yoshinori Hasegawa; Hiroshi Arima
Journal:  J Immunother Cancer       Date:  2020-07       Impact factor: 13.751

Review 3.  A narrative review of progress in diagnosis and treatment of small cell lung cancer patients with hyponatremia.

Authors:  Ranpu Wu; Chuling Li; Zimu Wang; Hang Fan; Yong Song; Hongbing Liu
Journal:  Transl Lung Cancer Res       Date:  2020-12

4.  The V2 receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells.

Authors:  G Marroncini; C Anceschi; L Naldi; B Fibbi; F Baldanzi; M Maggi; A Peri
Journal:  J Endocrinol Invest       Date:  2022-05-23       Impact factor: 5.467

5.  Prevalence and Prognostic Significance of Hyponatremia in Patients With Lung Cancer: Systematic Review and Meta-Analysis.

Authors:  Eszter Bartalis; Marin Gergics; Benedek Tinusz; Mária Földi; Szabolcs Kiss; Dávid Németh; Margit Solymár; Zsolt Szakács; Péter Hegyi; Emese Mezösi; László Bajnok
Journal:  Front Med (Lausanne)       Date:  2021-12-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.